Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 |
| Revenues | 284.0 | 110.0 |
| Revenue growth | 158.2% | |
| Cost of goods sold | 0.0 | 0.0 |
| Gross profit | 284.0 | 110.0 |
| Gross margin | 100.0% | 100.0% |
| Research and development | 6,097.9 | 5,380.1 |
| General and administrative | 3,639.7 | 3,951.4 |
| EBIT | -9,453.6 | -9,221.5 |
| EBIT margin | -3328.7% | -8383.1% |
| Pre-tax income | -10,680.4 | -8,939.7 |
| Income taxes | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% |
| Net income | -13,449.4 | -11,708.7 |
| Net margin | -4735.7% | -10644.2% |
| |
| Diluted EPS | ($90.47) | ($79.49) |
| Shares outstanding (diluted) | 148.7 | 147.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|